Renovorx Stock Market Value
| RNXT Stock | USD 0.93 0.04 4.12% |
| Symbol | RenovoRx |
Is there potential for Biotechnology market expansion? Will RenovoRx introduce new products? Factors like these will boost the valuation of RenovoRx. Anticipated expansion of RenovoRx directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about RenovoRx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of RenovoRx is measured differently than its book value, which is the value of RenovoRx that is recorded on the company's balance sheet. Investors also form their own opinion of RenovoRx's value that differs from its market value or its book value, called intrinsic value, which is RenovoRx's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because RenovoRx's market value can be influenced by many factors that don't directly affect RenovoRx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between RenovoRx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding RenovoRx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, RenovoRx's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
RenovoRx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to RenovoRx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of RenovoRx.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in RenovoRx on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding RenovoRx or generate 0.0% return on investment in RenovoRx over 90 days. RenovoRx is related to or competes with Elutia, Lantern Pharma, Reviva Pharmaceuticals, MAIA Biotechnology, Annovis Bio, Tvardi Therapeutics, and Celularity. RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid t... More
RenovoRx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure RenovoRx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess RenovoRx upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.76 | |||
| Information Ratio | 0.0059 | |||
| Maximum Drawdown | 29.68 | |||
| Value At Risk | (6.54) | |||
| Potential Upside | 8.33 |
RenovoRx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for RenovoRx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as RenovoRx's standard deviation. In reality, there are many statistical measures that can use RenovoRx historical prices to predict the future RenovoRx's volatility.| Risk Adjusted Performance | 0.0249 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0058 | |||
| Treynor Ratio | 0.0452 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of RenovoRx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
RenovoRx February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0249 | |||
| Market Risk Adjusted Performance | 0.0552 | |||
| Mean Deviation | 4.15 | |||
| Semi Deviation | 5.34 | |||
| Downside Deviation | 5.76 | |||
| Coefficient Of Variation | 4961.59 | |||
| Standard Deviation | 5.65 | |||
| Variance | 31.95 | |||
| Information Ratio | 0.0059 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0058 | |||
| Treynor Ratio | 0.0452 | |||
| Maximum Drawdown | 29.68 | |||
| Value At Risk | (6.54) | |||
| Potential Upside | 8.33 | |||
| Downside Variance | 33.14 | |||
| Semi Variance | 28.54 | |||
| Expected Short fall | (5.00) | |||
| Skewness | (0.57) | |||
| Kurtosis | 3.36 |
RenovoRx Backtested Returns
RenovoRx appears to be very risky, given 3 months investment horizon. RenovoRx maintains Sharpe Ratio (i.e., Efficiency) of 0.0745, which implies the firm had a 0.0745 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for RenovoRx, which you can use to evaluate the volatility of the company. Please evaluate RenovoRx's Semi Deviation of 5.34, risk adjusted performance of 0.0249, and Coefficient Of Variation of 4961.59 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, RenovoRx holds a performance score of 5. The company holds a Beta of 2.3, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, RenovoRx will likely underperform. Please check RenovoRx's potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether RenovoRx's historical price patterns will revert.
Auto-correlation | 0.31 |
Below average predictability
RenovoRx has below average predictability. Overlapping area represents the amount of predictability between RenovoRx time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of RenovoRx price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current RenovoRx price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.